Progesterone and the Prolonged Progestational State: Co-Carcinogenic Factors in Mammary Tumor Induction
1963

Progesterone and Mammary Tumors

Sample size: 125 publication Evidence: moderate

Author Information

Author(s): W. E. Poel

Primary Institution: Graduate School of Public Health, University of Pittsburgh

Hypothesis

Does prolonged exposure to progesterone enhance mammary tumor development in mice?

Conclusion

Progesterone was found to be a potent co-carcinogen for the induction and development of mammary tumors in mice.

Supporting Evidence

  • All mice treated with both progesterone and a carcinogen developed tumors before any other group.
  • Group I had a tumor incidence of 100% after 22 weeks of treatment.
  • Progesterone treatment was associated with a higher incidence of mammary tumors.

Takeaway

This study found that giving progesterone to mice can help tumors grow faster, which is important for understanding how it might affect humans.

Methodology

C3H mice were treated with progesterone and a carcinogenic solution to observe tumor development.

Limitations

The study is limited to the first 27 weeks of observation and may not fully represent long-term effects.

Participant Demographics

C3H female mice, 9 to 10 weeks of age.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication